[
    [
        {
            "time": "",
            "original_text": "北上资金今日净买入五粮液12.61亿元、贵州茅台10.16亿元，净卖出伊利股份5.97亿元、药明康德2.95亿元。",
            "features": {
                "keywords": [
                    "北上资金",
                    "净买入",
                    "五粮液",
                    "贵州茅台",
                    "净卖出",
                    "伊利股份",
                    "药明康德"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金今日净买入五粮液12.61亿元、贵州茅台10.16亿元，净卖出伊利股份5.97亿元、药明康德2.95亿元。",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "北向资金连续4日净买入累计加仓超170亿，批量扫货白酒股。",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "加仓",
                    "白酒股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金连续4日净买入累计加仓超170亿，批量扫货白酒股。",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "江苏区域股股市周报：新增4家上市公司，85家机构调研斯莱克。",
            "features": {
                "keywords": [
                    "江苏区域",
                    "上市公司",
                    "机构调研",
                    "斯莱克"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "区域经济"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "江苏区域股股市周报：新增4家上市公司，85家机构调研斯莱克。",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：CDE发布《以临床价值为导向的抗肿瘤药物临床研发指导原则》。",
            "features": {
                "keywords": [
                    "医药生物",
                    "CDE",
                    "临床价值",
                    "抗肿瘤药物",
                    "研发指导原则"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：CDE发布《以临床价值为导向的抗肿瘤药物临床研发指导原则》。",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "覆盖强生、默沙东等大客户，药明康德等CXO龙头股境外收入占比已超50%。",
            "features": {
                "keywords": [
                    "药明康德",
                    "CXO",
                    "龙头股",
                    "境外收入",
                    "强生",
                    "默沙东"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "覆盖强生、默沙东等大客户，药明康德等CXO龙头股境外收入占比已超50%。",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "前沿 | 合全药业与阿斯利康联合发表！KRAS抑制剂原料药工艺优化满足大规模生产需求。",
            "features": {
                "keywords": [
                    "合全药业",
                    "阿斯利康",
                    "KRAS抑制剂",
                    "原料药",
                    "工艺优化",
                    "大规模生产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "前沿 | 合全药业与阿斯利康联合发表！KRAS抑制剂原料药工艺优化满足大规模生产需求。",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "清华大学统计学研究中心胡志睿课题组诚聘博士后，统计学、生物信息学、计算机等相关专业。",
            "features": {
                "keywords": [
                    "清华大学",
                    "统计学",
                    "胡志睿",
                    "博士后",
                    "生物信息学",
                    "计算机"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "教育",
                    "科研"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "清华大学统计学研究中心胡志睿课题组诚聘博士后，统计学、生物信息学、计算机等相关专业。",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 1,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 1,
                "Time_Proximity": 5,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        }
    ]
]